Hexiao Tang

Also affiliated with Zhongnan Hospital of Wuhan University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Incidental use of angiotensin system inhibitors during neoadjuvant therapy for esophageal adenocarcinoma: An analysis of survival”.

Incidental use of angiotensin system inhibitors during neoadjuvant therapy for esophageal adenocarcinoma: An analysis of survival

Journal of Thoracic and Cardiovascular Surgery(2025)10.1016/j.jtcvs.2025.02.012

N/A

0DataRank · unranked

3 citations

Eric Abston, Ashok Muniappan, Christina L. Costantino, Hexiao Tang, Michael Lanuti +1 more

Editorial: EGFR-TKIs for lung cancer treatment: development, application, and side effects

Frontiers in Oncology(2025)10.3389/fonc.2025.1617788

N/A

0DataRank · unranked

2 citations

Hexiao Tang, Shengxi Chen, Qinglin Shen

Reply: Angiotensin system inhibitors deserve further evaluation in the neoadjuvant treatment of resectable esophageal adenocarcinoma

Journal of Thoracic and Cardiovascular Surgery(2025)10.1016/j.jtcvs.2025.05.001

N/A

0DataRank · unranked

0 citations

Abraham Geller, Ashok Muniappan, Christina L. Costantino, Hexiao Tang, Michael Lanuti +1 more